We used the canonical Wnt pathway inhibitor, ETC-159, to inhibit the activity of this pathway in A549 cells to investigate whether the function of Ube2S in NSCLC depended on activating this pathway. Here, UBE2S is linked to non-small cell lung carcinoma.